Results: 102
Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00339-8
- By:
- Publication type:
- Article
The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00337-w
- By:
- Publication type:
- Article
Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00331-2
- By:
- Publication type:
- Article
The deubiquitinase USP10 protects pancreatic cancer cells from endoplasmic reticulum stress.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00336-x
- By:
- Publication type:
- Article
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00330-3
- By:
- Publication type:
- Article
Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00334-z
- By:
- Publication type:
- Article
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00333-0
- By:
- Publication type:
- Article
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00335-y
- By:
- Publication type:
- Article
Author Correction: Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00329-w
- By:
- Publication type:
- Article
MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00328-x
- By:
- Publication type:
- Article
Clinical prospects of WRN inhibition as a treatment for MSI tumours.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00319-y
- By:
- Publication type:
- Article
Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profiling.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00325-0
- By:
- Publication type:
- Article
Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00327-y
- By:
- Publication type:
- Article
Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00324-1
- By:
- Publication type:
- Article
Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiency.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00326-z
- By:
- Publication type:
- Article
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00323-2
- By:
- Publication type:
- Article
Prediction of early-stage melanoma recurrence using clinical and histopathologic features.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00321-4
- By:
- Publication type:
- Article
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00322-3
- By:
- Publication type:
- Article
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00317-0
- By:
- Publication type:
- Article
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00316-1
- By:
- Publication type:
- Article
Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00320-5
- By:
- Publication type:
- Article
A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00262-y
- By:
- Publication type:
- Article
Single-cell spatial architectures associated with clinical outcome in head and neck squamous cell carcinoma.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00253-z
- By:
- Publication type:
- Article
Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00251-1
- By:
- Publication type:
- Article
HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00250-8
- By:
- Publication type:
- Article
Multimodal analysis suggests differential immuno-metabolic crosstalk in lung squamous cell carcinoma and adenocarcinoma.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00248-2
- By:
- Publication type:
- Article
Functional characterization of NPM1–TYK2 fusion oncogene.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00246-4
- By:
- Publication type:
- Article
SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00310-7
- By:
- Publication type:
- Article
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14).
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00315-2
- By:
- Publication type:
- Article
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00318-z
- By:
- Publication type:
- Article
Single-cell transcriptomic profiling for inferring tumor origin and mechanisms of therapeutic resistance.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00314-3
- By:
- Publication type:
- Article
Pharmacometabolomics reveals urinary diacetylspermine as a biomarker of doxorubicin effectiveness in triple negative breast cancer.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00313-4
- By:
- Publication type:
- Article
MatchMiner: an open-source platform for cancer precision medicine.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00312-5
- By:
- Publication type:
- Article
Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00311-6
- By:
- Publication type:
- Article
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00309-0
- By:
- Publication type:
- Article
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00301-8
- By:
- Publication type:
- Article
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00307-2
- By:
- Publication type:
- Article
Impact of TP53 mutations in Triple Negative Breast Cancer.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00303-6
- By:
- Publication type:
- Article
Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00308-1
- By:
- Publication type:
- Article
Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00306-3
- By:
- Publication type:
- Article
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00304-5
- By:
- Publication type:
- Article
Spatially variant immune infiltration scoring in human cancer tissues.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00305-4
- By:
- Publication type:
- Article
Reclassifying tumour cell cycle activity in terms of its tissue of origin.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00302-7
- By:
- Publication type:
- Article
Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00300-9
- By:
- Publication type:
- Article
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00299-z
- By:
- Publication type:
- Article
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00297-1
- By:
- Publication type:
- Article
A single-cell based precision medicine approach using glioblastoma patient-specific models.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00294-4
- By:
- Publication type:
- Article
A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00290-8
- By:
- Publication type:
- Article
Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00295-3
- By:
- Publication type:
- Article